Quantitative diffusion weighted imaging measures in patients with multiple sclerosis

NeuroImage

Volumn 36, Issue 3, 2007, Pages 746-754

  Tavazzi, Eleonora ^a,b   Dwyer, Michael G ^a   Weinstock Guttman, Bianca ^c   Lema, Jordan ^a   Bastianello, Stefano ^b   Bergamaschi, Roberto ^b   Cosi, Vittorio ^b   Benedict, Ralph H B ^a,c   Munschauer III, Frederick E ^c   Zivadinov, Robert ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b IRCCS   (Italy)

^c JACOBS NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Brain atrophy; Clinical disability; Diffusion imaging; Entropy; Lesion volume; Mean diffusivity; MRI; Multiple sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; DISEASE SEVERITY; ENTROPY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; WHITE MATTER;

ADOLESCENT; ADULT; AGED; BRAIN; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; ENTROPY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 34250162446     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.03.056     Document Type: Article

References (31)

1. Benedict, R.H.B., Bruce, J., Dwyer, M.G., Weinstock-Guttman, B., Tjoa, C.W., Tavazzi, E., et al., in press. Diffusion weighted imaging predicts cognitive impairment in multiple sclerosis. Mult Scler.
2. Castriota Scanderbeg A., Tomaiuolo F., Sabatini U., Nocentini U., Grasso M.G., and Caltagirone C. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. AJNR Am. J. Neuroradiol. 21 (2000) 862-868
3. Cercignani M., Iannucci G., and Filippi M. Diffusion-weighted imaging in multiple sclerosis. Ital. J. Neurol. Sci. 20 (1999) S246-S249
4. Cercignani M., Iannucci G., Rocca M.A., Comi G., Horsfield M.A., and Filippi M. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 54 (2000) 1139-1144
5. Cercignani M., Bozzali M., Iannucci G., Comi G., and Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 70 (2001) 311-317
6. Cercignani M., Inglese M., Pagani E., Comi G., and Filippi M. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am. J. Neuroradiol. 22 (2001) 952-958
7. Cohen J. Statistical Power for the Behavioral Sciences (1988), Lawrence Erlbaum Associates, Inc, Hillsdale, NJ
8. Droogan A.G., Clark C.A., Werring D.J., Barker G.J., McDonald W.I., and Miller D.H. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn. Reson. Imaging 17 (1999) 653-661
9. Fabiano A.J., Sharma J., Weinstock-Guttman B., Munschauer III F.E., Benedict R.H., Zivadinov R., et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J. Neuroimaging 13 (2003) 307-314
10. Filippi M., Campi A., Dousset V., Baratti C., Martinelli V., Canal N., et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45 (1995) 478-482
11. Filippi M., Iannucci G., Cercignani M., Assunta Rocca M., Pratesi A., and Comi G. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch. Neurol. 57 (2000) 1017-1021
12. Ge Y., Grossman R.I., Udupa J.K., Babb J.S., Mannon L.J., and McGowan J.C. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J. Comput. Assist. Tomogr. 26 (2002) 62-68
13. Horsfield M.A., Rovaris M., Rocca M.A., Rossi P., Benedict R.H., Filippi M., et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J. Neurol. Sci. 216 (2003) 169-177
14. Husted C.A., Goodin D.S., Hugg J.W., Maudsley A.A., Tsuruda J.S., de Bie S.H., et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann. Neurol. 36 (1994) 157-165
15. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
16. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
17. Miller D.H., Barkhof F., Berry I., Kappos L., Scotti G., and Thompson A.J. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J. Neurol. Neurosurg. Psychiatry 54 (1991) 683-688
18. Nusbaum A.O., Tang C.Y., Wei T., Buchsbaum M.S., and Atlas S.W. Whole-brain diffusion MR histograms differ between MS subtypes. Neurology 54 (2000) 1421-1427
19. Rovaris M., Gass A., Bammer R., Hickman S.J., Ciccarelli O., Miller D.H., et al. Diffusion MRI in multiple sclerosis. Neurology 65 (2005) 1526-1532
20. Roychowdhury S., Maldjian J.A., and Grossman R.I. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am. J. Neuroradiol. 21 (2000) 869-874
21. Sarchielli P., Presciutti O., Tarducci R., Gobbi G., Alberti A., Pelliccioli G.P., et al. 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study. J. Neurol. Neurosurg. Psychiatry 64 (1998) 204-212
22. Schmierer K., Altmann D.R., Kassim N., Kitzler H., Kerskens C.M., Doege C.A., et al. Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Mult. Scler. 10 (2004) 182-187
23. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 17 (2002) 143-155
24. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17 (2002) 479-489
25. Tortorella C., Viti B., Bozzali M., Sormani M.P., Rizzo G., Gilardi M.F., et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 54 (2000) 186-193
26. Tourbah A., Stievenart J.L., Abanou A., Fontaine B., Cabanis E.A., and Lyon-Caen O. Correlating multiple MRI parameters with clinical features: an attempt to define a new strategy in multiple sclerosis. Neuroradiology 43 (2001) 712-720
27. Wilson M., Morgan P.S., Lin X., Turner B.P., and Blumhardt L.D. Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 70 (2001) 318-322
28. Zivadinov R., and Bakshi R. Role of MRI in multiple sclerosis I: inflammation and lesions. Front. Biosci. 9 (2004) 665-683
29. Zivadinov R., Rudick R.A., De Masi R., Nasuelli D., Ukmar M., Pozzi-Mucelli R.S., et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 57 (2001) 1239-1247
30. Zivadinov R., Sepcic J., Nasuelli D., De Masi R., Bragadin L.M., Tommasi M.A., et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 70 (2001) 773-780
31. Zivadinov R., Dwyer G., and Watts L. Measurement of cerebral grey and white matter atrophy from various MRI pulse sequences using different segmentation algorithms. J. Neurol. 251 (2004) S89